professional documents
home
Upload
docsters
Upload
INSTITUTE OF REPORT BRIEF • SEPTEMBER 2007 MEDICINE During an influenza pandemic, healthcare workers will be on the front lines delivering care to patients and preventing further spread of the disease. Protecting the more than 13 million healthcare workers in the United States from illness or from infecting their families or the patients in their care is critical to limiting morbidity and mortality and preventing progression of a pandemic. As the nation prepares for pandemic influenza, multiple avenues for protecting the health of the public are being carefully considered, ranging from rapid development of appropriate vaccines to quarantine plans should the need arise for their implementation. One vital aspect of pandemic influenza planning is the use of personal protective equipment (PPE)—the respirators, gowns, gloves, face shields, eye protection, and other equipment that will be used by healthcare workers and others in their day-to-day patient care responsibilities. In 2006, the National Personal Protective Technology Laboratory (NPPTL) at the National Institute for Occupational Safety and Health (NIOSH) asked the Institute of Medicine (IOM) to conduct a study on the personal protective equipment needed by healthcare workers in the event of an influenza pandemic. The IOM committee determined that there is an urgent need to address the lack of preparedness regarding effective PPE for use in an influenza pandemic. Three critical areas were identified that require expeditious research and policy action: • Commit to worker safety and appropriate use of PPE. • Understand influenza transmission. PERSONAL PROTECTIVE EQUIPMENT FOR HEALTHCARE WORKERS PREPARING FOR AN INFLUENZA PANDEMIC: There is an urgent need to address the lack of preparedness regarding effective personal protective equipment (PPE) for use in an influenza pandemic. • Innovate and strengthen PPE design, testing, and certification. UNDERSTAND INFLUENZA TRANSMISSION Although it has been 70 years since the influenza A virus was discovered and despite the recognition that influenza causes severe morbidity and substantial mortality each year across the globe, little is known about the mechanisms by which the influenza virus is transmitted between individuals. Due to this lack of information, it is not possible at the present time to definitively inform healthcare workers about what PPE is critical and what level of protection this equipment will provide in a pandemic. Advising the Nation. Improving Health. Improving worker safety necessitates an organizationwide dedication to the creation, implementation, evaluation, and maintenance of effective and current safety practices—a culture of safety. Debate continues about whether influenza transmission is primarily via the airborne or the droplet routes and the extent of the contribution of the contact route. Further, the aerosol-droplet continuum needs to be clarified as soon as possible in order to develop and implement effective prevention strategies. Without knowing the contributions of each of the possible route(s) of transmission, all routes must be considered probable and consequential, and the resources needed for prevention and control strategies cannot be rationally focused to maximize preparedness efforts. Influenza transmission research should become an immediate and short-term research priority so that effective prevention and control strategies can be developed and refined. Opportunities abound for building on prior research and applying new technologies, as well as advances in research fields such as aerobiology and mathematical modeling, to the study of seasonal influenza and avian influenza. A global research effort is needed for influenza transmission and prevention and could provide much needed answers in a relatively short time frame. Equally important is the development of the technology and expertise to study pandemic influenza when it occurs. In this time of preparation for an influenza pandemic, the realization of how little is known about critical aspects of the disease should prompt immediate action to coordinate multiple resources and a diversity of research expertise to address the unknowns regarding influenza transmission and prevention. COMMIT TO WORKER SAFETY AND APPROPRIATE USE OF PPE Because PPE works by acting as a barrier to hazardous agents, healthcare workers face challenges in wearing PPE that include difficulties in verbal communications and interactions with patients and family members, maintaining tactile sensitivity through gloves, and physiological burdens such as difficulties in breathing while wearing a respirator. Improving worker safety necessitates an organization-wide dedication to the creation, implementation, evaluation, and maintenance of effective and current safety practices—a culture of safety. Employees should feel uncomfortable when not wearing PPE during appropriate situations. Healthcare facilities need to foster and promote a strong culture of safety that includes a commitment to worker safety, adequate access to safety equipment, and extensive training efforts that utilize protocols requiring specific safety actions and detailing the consequences for noncompliance. Key components in promoting a culture of safety in healthcare facilities include: providing leadership and commitment to worker safety; emphasizing education and training; improving feedback and enforcement of PPE policies and use; and clarifying work practices and policies, including a commitment to expand and enforce regulatory policies. A concerted effort is needed to identify best practices in infection control and to disseminate this information to all sites where health care is provided. INNOVATE AND STRENGTHEN PPE DESIGN, TESTING, AND CERTIFICATION An integrated life-cycle approach is needed for healthcare PPE products. From the design of PPE that takes functionality, wearability, and other factors into account, to premarket testing that examines the types of wear and tear and use of PPE in the workplace, through post-marketing evaluations of actual use in healthcare facilities, healthcare PPE needs to be considered an essential component of worker safety with concomitant resources devoted to the research and development efforts essential for the comprehensive protection of healthcare workers. 2 EVIDENCE-BASED PERFORMANCE REQUIREMENTS Functionality • Protect against influenza virus • Guard against contact with contaminated fluids and aerosols Usability • Maintain biomechanical efficiency and sense of touch and feel • Odor-free • Hypoallergenic • Accommodate wide range of users (face and body profiles) • Compatibility across various elements of the PPE ensemble and with other equipment (e.g., stethoscope) • Non-startling to patients and families • Facilitate communication with others (verbal, facial) Comfort and wearability • Comfortable—no skin irritation or pressure points • Prolonged use without discomfort • Breathable—air permeable • Moisture absorbent— wickability • Low bulk and weight • Dimensional stability • Easy to put on and take off (don and doff) Maintenance and Reuse • Easy to decontaminate and discard disposable elements • Easy to clean and replace parts in reusable PPE Cost • Product cost • Total life-cycle cost • Minimal environmental impact Durability Aesthetics • Variety of styles and colors • Customizable • • • • Adequate wear life Strength—tear, tensile, burst Abrasion resistance Corrosion resistance In this era of moving toward preparedness for a pandemic, it is important to examine the level of rigor employed to ensure that all forms of PPE are deemed to be safe and effective medical devices. The varied regulatory, certification, and evaluation requirements for healthcare PPE have largely evolved in a fragmented manner and have not focused on the hazards of exposure to infectious agents. Many federal agencies have a distinct and vital role in ensuring the use of effective PPE, and there is a strong need for a coordinated effort to ensure harmonization of requirements and to focus on the entire process from product design (utilizing evidence-based performance requirements) to use in the workplace. Further, there are substantial gaps in knowledge regarding the design and implementation of PPE for family members and others who will provide care to influenza patients during a pandemic or who wish to use preventive measures to avoid influenza transmission. Until more is known about influenza transmission, it will be critical to follow current infection control practices, to ensure that all available forms of protections are available to healthcare workers, and to heighten their knowledge of PPE and its use, while also obtaining the input of healthcare workers in designing, testing, and developing the next generation of PPE. The committee believes that improvements can be made so that healthcare workers will have PPE that provides protection against influenza transmission based on a rigorous risk assessment with solid scientific evidence. In this era of moving toward preparedness for a pandemic, it is important to examine the level of rigor employed to ensure that all forms of PPE are deemed to be safe and effective medical devices. 3 OVERVIEW OF THE REPORT‘S RECOMMENDATIONS Understand Influenza Transmission • Initiate and Support a Global Influenza Research Network • Strengthen Pre-market Testing of PPE for Healthcare Workers • Strengthen Post-market Evaluation of PPE for Healthcare Workers • Coordinate Efforts and Expand Resources for Research and Approval of PPE • Emphasize Appropriate PPE Use in Patient Care and in Healthcare Management, Accreditation, and Training • Identify and Disseminate Best Practices for Improving PPE Compliance and Use • Increase Research and Research Translation Efforts Relevant to PPE Compliance Innovate and Strengthen PPE Design, Testing, and Certification • Define Evidence-Based Performance Requirements (Prescriptive Standards) for PPE • Adopt a Systems Approach to the Design and Development of PPE • Increase Research on the Design and Engineering of the Next Generation of PPE • Establish Measures to Assess and Compare the Effectiveness of PPE • Ensure Balance and Transparency of Standards-Setting Processes Commit to Worker Safety and Appropriate Use of PPE Copies of Preparing for an Influenza Pandemic: Personal Protective Equipment for Healthcare Workers are available from the National Academies Press, 500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 6246242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap.edu. The full text of this report is available at http://www.nap.edu. This study was supported by funds from the National Institute for Occupational Safety and Health. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the organization that provided support for the project. The Institute of Medicine serves as adviser to the nation to improve health. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public. For more information about the Institute of Medicine, visit the IOM web site at www.iom.edu. Permission is granted to reproduce this document in its entirety, with no additions or alterations. Copyright © 2007 by the National Academy of Sciences. All rights reserved. FOR MORE INFORMATION… LEWIS R. GOLDFRANK (Chair), New York University Medical Center, New York; HOWARD J. COHEN, University of New Haven, West Haven, Connecticut; JANINE JAGGER, University of Virginia, Charlottesville; SUNDARESAN JAYARAMAN, Georgia Institute of Technology, Atlanta; TALMADGE E. KING, JR., University of California, San Francisco; DONALD LOW, University of Toronto, Ontario, Canada; SHARON MARABLE, Brown University, Providence, Rhode Island; R. KENT OESTENSTAD, University of Alabama School of Medicine, Birmingham; TRISH M. PERL, Johns Hopkins University School of Medicine, Baltimore; DAVID PREZANT, Albert Einstein College of Medicine, Brooklyn, New York; M.E. BONNIE ROGERS, University of North Carolina School of Public Health, Chapel Hill. COMMITTEE ON PERSONAL PROTECTIVE EQUIPMENT FOR HEALTHCARE WORKERS DURING AN INFLUENZA PANDEMIC STAFF 4 CATHARYN T. LIVERMAN, Project Director; FRANKLIN BRANCH, Research Associate (since April 2007); NORA HENNESSY, Research Associate (until March 2007); JUDITH ESTEP, Program Associate.
flag this doc
124
0
1(1)
1
5/6/2008
English
Preview

The Centers for Disease Control and Prevention CDC

CDCdocs 5/6/2008 | 464 | 10 | 0 | legal
Preview

Georgia Centers for Disease Control and Prevention

CDCdocs 5/6/2008 | 191 | 2 | 0 | legal
Preview

Centers for Disease Control and Prevention Centers for

CDCdocs 5/5/2008 | 153 | 0 | 0 | legal
Preview

Centers for Disease Control and Prevention Division of

CDCdocs 5/6/2008 | 147 | 2 | 0 | legal
Preview

The Centers for Disease Control and Prevention CDC - Health Concerns

CDCdocs 5/6/2008 | 171 | 0 | 0 | legal
Preview

Centers for Disease Control and Prevention National Center

CDCdocs 5/6/2008 | 144 | 0 | 0 | legal
Preview

Centers For Disease Control and Prevention National Conference - View Webcasts

CDCdocs 5/5/2008 | 91 | 0 | 0 | legal
Preview

Centers for Disease Control and Prevention National Institute - 2004

CDCdocs 5/5/2008 | 97 | 0 | 0 | legal
Preview

Centers for Disease Control and Prevention Division of - slides)

CDCdocs 5/6/2008 | 107 | 1 | 0 | legal
Preview

Centers for Disease Control and Prevention Budget Request

CDCdocs 5/6/2008 | 151 | 0 | 0 | legal
Preview

Centers for Disease Control and Prevention Budget Request - Budget Documents

CDCdocs 5/6/2008 | 92 | 0 | 0 | legal
Preview

Georgia Centers for Disease Control and Prevention - CADDRE

CDCdocs 5/6/2008 | 136 | 0 | 0 | legal
Preview

?associated Disease

CDCdocs 5/5/2008 | 83 | 0 | 0 | legal
Preview

Infectious Disease Knowledge Center

CDCdocs 5/6/2008 | 66 | 2 | 0 | legal
Preview

Centers for Disease Control and Prevention Outbreak of acute illness southwestern United States

CDCdocs 5/5/2008 | 176 | 1 | 0 | legal
Preview

Laboratory Procedure Manual Analyte Urinary Albumin Urine Sequoia

CDCdocs 5/8/2008 | 213 | 2 | 0 | legal
Preview

Lab Total Cholesterol HDL Cholesterol Triglycerides and LDL Cholesterol

CDCdocs 5/8/2008 | 277 | 3 | 0 | legal
Preview

Laboratory Procedure Manual Analyte Matrix Method Parathyroid Hormone

CDCdocs 5/8/2008 | 138 | 2 | 0 | legal
Preview

Lab Total Prostate Specific Antigen

CDCdocs 5/8/2008 | 200 | 3 | 0 | legal
Preview

Lab Free Prostate Specific Antigen

CDCdocs 5/8/2008 | 133 | 2 | 0 | legal
Preview

Lab C Reactive Protein

CDCdocs 5/8/2008 | 231 | 2 | 1 | legal
Preview

Laboratory Procedure Manual Analyte Matrix Method Insulin Serum

CDCdocs 5/8/2008 | 121 | 0 | 0 | legal
Preview

Lab Bone Alkaline Phosphatase

CDCdocs 5/8/2008 | 164 | 0 | 0 | legal
Preview

Laboratory Procedure Manual Analyte Matrix Method Mercury Urine

CDCdocs 5/8/2008 | 128 | 1 | 0 | legal
Preview

Laboratory Procedure Manual Analyte Matrix Method Vitamin C

CDCdocs 5/8/2008 | 128 | 0 | 0 | legal
 
review this doc
Spread of avian flu by drinking water:
Rated 1 out of 10

May 09, 2008 (4 months 31 days ago)Spread of avian flu by drinking water can explain small clusters in households. Proved awareness to ecology and transmission is necessary to understand the spread of avian flu. For this it is insufficient exclusive to test samples from wild birds, poultry and humans for avian flu viruses. Samples from the known abiotic vehicles also have to be analysed. There are plain links between the cold, rainy seasons as well as floods and the spread of avian flu. That is just why abiotic vehicles have to be analysed. The direct biotic transmission from birds, poultry or humans to humans can not depend on the cold, rainy seasons or floods. Water is a very efficient abiotic vehicle for the spread of viruses - in particular of fecal as well as by mouth, nose and eyes excreted viruses. Infected birds and poultry can everywhere contaminate the drinking water. All humans have very intensive contact to drinking water. To prove viruses in water is difficult because of dilution. If you find no viruses you can not be sure that there are not any. On the other hand in water viruses remain viable for a long time. Water has to be tested for influenza viruses by cell culture and in particular by the more sensitive molecular biology method PCR. There is a widespread link between avian flu and water, e.g. in Egypt to the Nile delta or Indonesia to residential districts of less prosperous humans with backyard flocks and without central water supply as in Vietnam: http://www.cdc.gov/ncidod/EID/vol12no12/06-0829.htm. See also the WHO web side: http://www.who.int/water_sanitation_health/emerging/h5n1background.pdf . Transmission of avian flu by direct contact to infected poultry is an unproved assumption from the WHO. There is no evidence that influenza primarily is transmitted by saliva droplets: “Transmission of influenza A in human beings” http://www.thelancet.com/journals/laninf/article/PIIS1473309907700294/abstract?iseop=true . Avian flu infections may increase in consequence to increase of virus circulation. In hot climates/the tropics flood-related influenza is typical after extreme weather and floods. Virulence of influenza viruses depends on temperature and time. Special in cases of local water supplies with “young” and fresh H5N1 contaminated water from low local wells, cisterns, tanks, rain barrels, ponds, rivers or rice paddies this pathway can explain small clusters in households. At 24°C e.g. in the tropics the virulence of influenza viruses in water amount to 2 days. In temperate climates for “older” water from central water supplies cold water is decisive to virulence of viruses. At 7°C the virulence of influenza viruses in water amount to 14 days. Human to human and contact transmission of influenza occur - but are overvalued immense. In the course of influenza epidemics in Germany, recognized clusters are rare, accounting for just 9 percent of cases e.g. in the 2005 season. In temperate climates the lethal H5N1 virus will be transferred to humans via cold drinking water, as with the birds in February and March 2006, strong seasonal at the time when drinking water has its temperature minimum. The performance to eliminate viruses from the drinking water processing plants regularly does not meet the requirements of the WHO and the USA/USEPA. Conventional disinfection procedures are poor, because microorganisms in the water are not in suspension, but embedded in particles. Even ground water used for drinking water is not free from viruses. http://www.un.org/apps/news/story.asp?NewsID=26096